MSB 2.98% $1.47 mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-374

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,706 Posts.
    lightbulb Created with Sketch. 6969
    1870 now is the US daiily deaths tally for today. I am really started to get frustrated now by the tardiness of NIH. THis trial should have been done and dusted by now. REM_L, presuming it is efficacious, out there saving lives, rather than the crappy anti-virals and other treatments doing nothing. If you understand the pathogenisis of COVID-19 ARDS and the mechanisms of REM-L in reversing cyctokine storms you cannot help but believe it can save countless otherwise lost lives.

    That people believe the vaccine is going to immediately save the day is a sad reflection of the lack of perspective people have. 60% of Americans said they will get a vaccine in November. That ones a little like only 30% of people said they'd vote for Trump. It will be 50% at test and it will not be before end of 2021 in the US alone. I am buying into any MSB dips....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.